Facilitating Neuroplastic Changes of Acute Stroke Survivors
Facilitating Neuroplastic Changes of Acute Stroke Survivors With Severe Hemiplegia
University of Maryland, Baltimore
68 participants
Jun 1, 2025
INTERVENTIONAL
Conditions
Summary
This project will develop a wearable rehabilitation robot suitable for in-bed acute stage rehabilitation. It involves robot-guided motor relearning, passive and active motor-sensory rehabilitation early in the acute stage post-stroke including patients who are paralyzed with no motor output. The early acute stroke rehabilitation device will be evaluated in this clinical trial.
Eligibility
Inclusion Criteria5
- Acute first time unilateral hemispheric stroke (hemorrhagic or ischemic stroke, 24 hours after admission to 1 month post-stroke at the start of the proposed treatment)
- Hemiplegia or hemiparesis
- ≤Manual Muscle Testing (MMT)<=2
- Age 30-85
- Ankle impairments including stiff calf muscles and/or inadequate dorsiflexion
Exclusion Criteria8
- Medically not stable
- Associated acute medical illness that interferes with ability to training and exercise
- No impairment or very mild ankle impairment of ankle
- Severe cardiovascular problems that interfere with ability to perform moderate movement exercises
- Cognitive impairment or aphasia with inability to follow instructions
- Severe pain in legs
- Severe ankle contracture greater than 15° plantar flexion (when pushing ankle to dorsiflexion)
- Pressure ulcer, recent surgical incision or active skin disease with open wounds present below knee
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Ankle motor control relearning training under real-time feedback
Passive stretching under intelligent robotic control
Active movement training through movement games with robotic assistance
Passive movement in the joint middle range of motion
Active movement training without robotic assistance
Ankle torque and motion measurement with no real-time feedback
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06404268